Julianne will work with us to educate, inform and campaign as a high profile entrepreneur who lives with anaphylaxis. Julianne Ponan (31) didn’t start out wanting to be an entrepreneur. She began her career in finance and took her first

As an ambassador Julianne will work with us to educate, inform and campaign as a high profile entrepreneur who has lived with anaphylaxis since childhood. Julianne Ponan was a toddler when she had her first anaphylactic attack. At nursery after

Please take part in the international survey on Psychological Service Needs for Food Allergy headed by Dr Rebecca Knibb at Aston University in collaboration Dr Chrissie Jones, Dr Helen Brough, Dr Linda Herbert, Mary Jane Marchisotto, Centres in the UK,

We really welcome the Editorial in the BMJ (18th January 2021)-  “Vaccinating against Covid 19 in People who report Allergies.” Click here to read the editorial The Campaign has had an unprecedented number of calls to our helpline from allergic

We are saddened to learn of the tragic death of Ellen Raffell, aged 16, who sadly died on 31st October 2019. We would like to offer our deepest sympathies to her family at this difficult time. Following the inquest on

Shrimp allergy is a common and serious food allergy that is underdiagnosed and often lifelong.

Acaster Lloyd Consulting are looking for participants to take part in a research study about caregivers’ and children’s Experiences of taking an oral peanut protein powder (immunotherapy) treatment or 2. Their thoughts about how an oral peanut protein powder (immunotherapy)

Aimmune Therapeutics’ PALFORZIA® has been approved by the European Commission as a treatment for peanut allergy. The European Commission (EC) has approved PALFORZIA®  for the treatment of peanut allergy, making it the first treatment for the condition. Produced by Aimmune

Allergy Therapeutics PLC – Sussex-based biotechnology firm focused on allergy vaccines – Initiates peanut allergy biomarker study with Imperial College London to confirm potential of novel peanut vaccine candidate. The study aims to evaluate the novel virus like particle based